Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus rhamnosus for Uremic Toxins in Hemodialysis
NCT03527680Completed
- Start
- Sep 2016
- Primary completion
- Nov 2016
01
Overview
Randomised, double-blind trial in uremic toxicity. Primary endpoint: p-cresol at 4 weeks. Started Sep 2016; status: completed.
02
Conditions
uremic toxicity
Beyond the preview
Go deeper on NCT03527680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03527680.